Figure 6 from Deuterium Metabolic Imaging Differentiates Glioblastoma Metabolic Subtypes and Detects Early Response to Chemoradiotherapy
- Abstract:
- <p>Histologic assessment of tumor cell proliferation and cell death before and 24 hours after treatment. <b>A-D,</b> Representative sections of A11 and S2 tumors stained for Ki67 (<b>A</b> and <b>B</b>) and CC3 (<b>C</b> and <b>D</b>) pre- and posttreatment with chemoradiation. <b>E-H,</b> The percentage of Ki67-positive cells for A11 (<b>E</b>) and S2 (<b>F</b>) tumors and the percentage of CC3-positive cells for A11 (<b>G</b>) and S2 (<b>H</b>) tumors before and at 24 hours after completion of treatment. **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001.</p>
- Authors:
- JCM Low, J Cao, F Hesse, AJ Wright, A Tsyben, I Alshamleh, R Mair, KM Brindle
- Publication date:
- 14th Jun 2024
- Full text
- DOI